A new UBC Physical Therapy & Research Clinic for people with neurological conditions has opened across the street from the Djavad Mowafaghian Centre for Brain Health, offering people living with movement disorders, stroke, and multiple sclerosis (MS) access to a group exercise program tailored to their specific needs.
You are hereNews & Events
Pictured: Dr. Anthony Trabouslee. Image credit: Paul Joseph/UBC.
Pictured: Dr. Carles Vilariño-Güell in his laboratory at the Djavad Mowafaghian Centre for Brain Health. Image credit: Paul Joseph/UBC.
An international team of researchers led by investigators at the Djavad Mowafaghian Centre for Brain Health at the University of British Columbia has made a scientific advance they hope will lead to the development of preventative treatments for multiple sclerosis (MS).
Dr. Alex Rauscher and his team are engaged in a long-term project to understand the effects of various tissue properties on the images produced by different magnetic resonance imaging (MRI) applications. His newest work, with postdoctoral fellow Dr. Christoph Birkl and published in the journal NeuroImage, offers a new perspective on the role of iron in myelin water imaging (MWI) and challenges existing interpretations of MWI findings in research literature.
A new computational tissue model from Dr. Alex Rauscher and his team has enabled the researchers to quantify brain myelin and iron from MRI scans, offering new clues as to the role of myelin and iron in tissue damage and disease progression in multiple sclerosis (MS).
A comprehensive review of existing research has found that any amount of exercise is good, but working out in different ways throughout the week is the best prescription for optimal cognitive and body function. The study, published recently in the journal Neurobiology of Aging, also found a relationship between improved physical health and improved overall brain health. Regular aerobic and resistance training also reduces frailty and its associated hazards in older adults.
A new study from Dr. Elaine Kingwell and Dr. Helen Tremlett reveals that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.
Neighbourhood income and education level is associated with risk of disability progression in patients with multiple sclerosis, suggests new research from Dr. Helen Tremlett and colleagues at the University of British Columbia.
More than 90,000 Canadians live with multiple sclerosis (MS) a chronic disease affecting the brain and central nervous system. It often affects young adults, with diagnosis generally occurring between 25 and 45 years of age. For those seeking to understand how MS affects individuals and populations, Canadian health data offers a wealth of information for researchers, with findings of relevance to all Canadians. Epidemiological data captured across Canada has, for many years, informed research and care across the country and, sometimes, in the United States (US).
“The world is mobilizing around a strategic approach to brain research,” says Dr. Judy Illes, “and neuroethics is an anchor point.”
While leaders in brain research around the world have been building toward an international brain research strategy, Canada has been working on a complementary approach that accelerates international efforts but leverages the unique advantages of Canadian researchers and Canada as a neuroscience-driven nation.